Status:

COMPLETED

Anti-inflammatory Effect of Platelet-Rıch Fıbrın

Lead Sponsor:

Nilay Er

Conditions:

Surgical Complication

Pain, Postoperative

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

This study evaluated the anti-inflammatory effect of platelet-rich fibrin (PRF) applied to the extraction socket after impacted mandibular third molar surgery with subjective and objective parameters....

Detailed Description

Operations All surgical procedures were performed by the same surgeon, with the same flap design and the same surgical technique. 2 ml of a local anesthetic solution containing 40 mg/ml articaine HCl ...

Eligibility Criteria

Inclusion

  • not have any systemic disease that will prevent tissue healing
  • no history of regular drug use
  • no drug allergies
  • not smoking
  • not being pregnant
  • having bilateral mandibular third molar tooth in class II, position B and C position according to Pell \& Gregory classification with the same root form, position and level of impaction
  • no signs of abscess, pericoronitis or inflammation before extraction

Exclusion

  • pregnancy
  • having a chronic disease
  • having a local infection in the impacted tooth area
  • smoking

Key Trial Info

Start Date :

October 10 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 22 2021

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT05336578

Start Date

October 10 2019

End Date

August 22 2021

Last Update

April 20 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Trakya University

Edirne, Merkez, Turkey (Türkiye), 22030

Anti-inflammatory Effect of Platelet-Rıch Fıbrın | DecenTrialz